Taniguchi H - Search Results

1

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer.

Yamaguchi K, Taniguchi H, Komori A, Narita Y, Nitta S, Nomura M, Kadowaki S, Takahari D, Ura T, Andoh M, Muro K, Mori K, Igarashi Y. Yamaguchi K, et al. Among authors: taniguchi h. BMC Cancer. 2015 Aug 27;15:601. doi: 10.1186/s12885-015-1606-1. BMC Cancer. 2015. PMID: 26311588 Free PMC article. Clinical Trial.

2

Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.

Sakamoto T, Yasui H, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Machida N, Todaka A, Tomita H, Tsushima T, Taniguchi H, Hamauchi S. Sakamoto T, et al. Among authors: taniguchi h. Int J Clin Oncol. 2010 Jun;15(3):287-93. doi: 10.1007/s10147-010-0054-9. Epub 2010 Mar 10. Int J Clin Oncol. 2010. PMID: 20217447

3

S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.

Yokota T, Onozawa Y, Boku N, Hamauchi S, Tsushima T, Taniguchi H, Todaka A, Machida N, Yamazaki K, Fukutomi A, Yasui H. Yokota T, et al. Among authors: taniguchi h. Jpn J Clin Oncol. 2011 Dec;41(12):1351-7. doi: 10.1093/jjco/hyr147. Epub 2011 Oct 5. Jpn J Clin Oncol. 2011. PMID: 21980053

4

Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.

Tsushima T, Hironaka S, Boku N, Machida N, Yamazaki K, Yasui H, Fukutomi A, Todaka A, Taniguchi H, Onozawa Y, Taku K. Tsushima T, et al. Among authors: taniguchi h. Int J Clin Oncol. 2013 Feb;18(1):10-6. doi: 10.1007/s10147-011-0335-y. Epub 2011 Oct 22. Int J Clin Oncol. 2013. PMID: 22020563

5

Modified FOLFOX-6 therapy for heavily pretreated advanced gastric cancer refractory to fluorouracil, irinotecan, cisplatin and taxanes: a retrospective study.

Tsuji K, Yasui H, Onozawa Y, Boku N, Doyama H, Fukutomi A, Yamazaki K, Machida N, Todaka A, Taniguchi H, Tsushima T, Yokota T. Tsuji K, et al. Among authors: taniguchi h. Jpn J Clin Oncol. 2012 Aug;42(8):686-90. doi: 10.1093/jjco/hys084. Epub 2012 Jun 11. Jpn J Clin Oncol. 2012. PMID: 22693245

6

Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy.

Takao M, Yamazaki K, Boku N, Ikehara H, Hamauchi S, Tsushima T, Taniguchi H, Todaka A, Machida N, Fukutomi A, Onozawa Y, Yasui H. Takao M, et al. Among authors: taniguchi h. Int J Clin Oncol. 2013 Oct;18(5):864-8. doi: 10.1007/s10147-012-0452-2. Epub 2012 Aug 7. Int J Clin Oncol. 2013. PMID: 22865286

7

Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.

Kadowaki S, Komori A, Narita Y, Nitta S, Yamaguchi K, Kondo C, Taniguchi H, Takahari D, Ura T, Ando M, Muro K. Kadowaki S, et al. Among authors: taniguchi h. Int J Clin Oncol. 2014 Aug;19(4):656-61. doi: 10.1007/s10147-013-0610-1. Epub 2013 Sep 3. Int J Clin Oncol. 2014. PMID: 23999902

8

CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy.

Narita Y, Taniguchi H, Komori A, Nitta S, Yamaguchi K, Kondo C, Nomura M, Kadowaki S, Takahari D, Ura T, Andoh M, Muro K. Narita Y, et al. Among authors: taniguchi h. Cancer Chemother Pharmacol. 2014 Feb;73(2):409-16. doi: 10.1007/s00280-013-2367-7. Epub 2013 Dec 10. Cancer Chemother Pharmacol. 2014. PMID: 24322376

9

Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.

Narita Y, Taniguchi H, Komori K, Kimura K, Kinoshita T, Komori A, Nomura M, Kadowaki S, Takahari D, Ura T, Andoh M, Muro K. Narita Y, et al. Among authors: taniguchi h. Int J Clin Oncol. 2015 Aug;20(4):755-60. doi: 10.1007/s10147-014-0772-5. Epub 2014 Nov 27. Int J Clin Oncol. 2015. PMID: 25424249

10

[Molecular biomarkers to predict outcome in colorectal cancer- current evidence and future perspectives].

Taniguchi H. Taniguchi H. Gan To Kagaku Ryoho. 2014 Nov;41(11):1367-71. Gan To Kagaku Ryoho. 2014. PMID: 25577804 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,987 results

Search Page

Filters